George Golumbeski

(Dr. George Golumbeski Ph.D.)

Currently holds positions in SAGE Therapeutics Inc, Enanta Pharmaceuticals Inc and MorphoSys AG

Positions

Position Company Period
Director SAGE Therapeutics Inc Jan. 23, 2019 -
Independent Director Enanta Pharmaceuticals Inc Feb. 7, 2014 -
Independent Member of the Supervisory Board MorphoSys AG May 17, 2018 -
Independent Director Acceleron Pharma Inc Jan. 1, 2011 - June 6, 2018
George Golumbeski's trades of SAGE Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-05-09 2022-05-05
B Purchase
8,000 +inf%
31.45
USD 251,563 		8,000 +inf% 31.45 USD 251,563
2022-04-27 2022-04-26
B Purchase
28,330 +107.8%
3.63
USD 102,838 		28,330 +107.8% 3.63 USD 102,838
2022-04-26 2022-04-22
B Purchase
234 +0.9%
3.67
USD 859 		234 +0.9% 3.67 USD 859
2022-04-26 2022-04-21
B Purchase
26,049 +inf%
3.69
USD 96,121 		26,049 +inf% 3.69 USD 96,121
2019-03-06 2019-03-04
PS Planned sale
9,280 -100.0%
103.65
USD 961,897 		9,280 -100.0% 103.65 USD 961,897
2019-02-13 2019-02-12
PS Planned sale
11,228 -100.0%
90.07
USD 1,011,301 		11,228 -100.0% 90.07 USD 1,011,301
2019-02-13 2019-02-11
PS Planned sale
2,272 -100.0%
90.03
USD 204,552 		2,272 -100.0% 90.03 USD 204,552
// ... existing code ... // ... rest of the file ...